Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.39%446.46M | 32.97%419.3M | 25.25%390.81M | 27.91%1.35B | 9.62%336.06M | 40.13%383.6M | 36.01%315.33M | 29.51%312.03M | 20.23%1.05B | 28.71%306.55M |
| Cost of revenue | 10.48%381.72M | 25.86%362.3M | 18.64%340.02M | 23.75%1.21B | 4.85%291.79M | 35.04%345.53M | 32.16%287.87M | 26.13%286.6M | 18.81%979.2M | 26.61%278.29M |
| Gross profit | 70.01%64.74M | 107.56%57M | 99.70%50.79M | 83.06%135.24M | 56.66%44.27M | 113.01%38.08M | 95.77%27.46M | 85.44%25.43M | 42.85%73.88M | 53.83%28.26M |
| Operating expense | 37.63%15.45M | 68.20%12.39M | 100.52%13.75M | 26.24%37.19M | 30.74%12.12M | 37.44%11.23M | 16.55%7.37M | 13.69%6.86M | 21.54%29.46M | 31.26%9.27M |
| Selling and administrative expenses | 38.49%15.45M | 68.22%12.39M | 100.52%13.75M | 25.72%37.44M | 30.73%12.12M | 36.60%11.16M | 16.53%7.37M | 13.69%6.86M | 22.53%29.78M | 29.85%9.27M |
| -Selling and marketing expense | 74.02%11.42M | 88.10%8.91M | 110.32%8.68M | 43.41%24.78M | 55.55%9.27M | 56.90%6.56M | 27.74%4.74M | 20.46%4.13M | 28.38%17.28M | 58.60%5.96M |
| -General and administrative expense | -12.23%4.03M | 32.38%3.48M | 85.72%5.07M | 1.28%12.66M | -14.00%2.85M | 15.30%4.6M | 0.61%2.63M | 4.80%2.73M | 15.28%12.5M | -2.13%3.31M |
| Other operating expenses | ---- | ---- | ---- | 3,126.84%72.6K | 100.00%2K | 6,900.00%70K | --1K | ---- | -75.07%2.25K | 133.61%1K |
| Total other operating income | ---- | ---- | ---- | -0.23%321.02K | ---- | ---- | ---- | ---- | 340.98%321.75K | ---- |
| Operating profit | 83.55%49.29M | 121.99%44.61M | 99.40%37.03M | 120.75%98.05M | 69.32%32.15M | 176.60%26.85M | 160.74%20.1M | 141.77%18.57M | 61.66%44.42M | 67.93%18.99M |
| Net non-operating interest income (expenses) | -24.57%-3.43M | -44.99%-3.24M | -39.22%-2.75M | 6.02%-8.17M | -19.38%-2.6M | -26.26%-2.76M | 6.60%-2.24M | 26.84%-1.98M | -6.74%-8.7M | -10.37%-2.18M |
| Non-operating interest income | ---- | ---- | ---- | 83.70%1.39M | ---- | ---- | ---- | ---- | 289.94%758.92K | ---- |
| Non-operating interest expense | 24.57%3.43M | 44.99%3.24M | 39.22%2.75M | 1.18%9.57M | 19.38%2.6M | 26.26%2.76M | -6.60%2.24M | -26.84%1.98M | 13.35%9.46M | 0.46%2.18M |
| Net investment income | -5.70%1.63M | 56.76%1.73M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | 184.11%1.08M | 378.57K | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1,258.12%-1.71M | -346.70%-1.76M | 91.79%-125.67K | -394K | ||||||
| Less:Other special charges | ---- | ---- | ---- | 80.11%-53.28K | ---- | ---- | ---- | ---- | -198.76%-267.83K | ---- |
| Less:Write off | ---- | ---- | ---- | 347.28%1.76M | 346.70%1.76M | ---- | ---- | ---- | -75.71%393.5K | --394K |
| Other non-operating income (expenses) | 131.98%972K | -19.32%714K | -20.30%1.57M | 5.36%1.42M | 2,872.22%2.68M | -62.32%419K | -50.14%885K | 7.57%1.98M | 40.59%1.35M | 103.72%90K |
| Income before tax | 91.01%46.83M | 124.50%42.08M | 93.07%35.86M | 136.36%92.3M | 84.57%30.47M | 183.82%24.52M | 164.45%18.74M | 172.44%18.57M | 96.63%39.05M | 154.50%16.51M |
| Income tax | 86.97%11.11M | 141.91%10.44M | 87.93%8.46M | 107.85%19.98M | 28.01%5.22M | 181.34%5.94M | 147.65%4.31M | 168.28%4.5M | 80.88%9.61M | 112.74%4.08M |
| Net income | 92.30%35.72M | 119.29%31.64M | 94.71%27.4M | 145.67%72.32M | 103.15%25.24M | 184.62%18.57M | 169.92%14.43M | 173.79%14.07M | 102.39%29.44M | 172.04%12.43M |
| Net income continuous operations | 92.30%35.72M | 119.29%31.64M | 94.71%27.4M | 145.67%72.32M | 103.15%25.24M | 184.62%18.57M | 169.92%14.43M | 173.79%14.07M | 102.39%29.44M | 172.04%12.43M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 92.30%35.72M | 119.29%31.64M | 94.71%27.4M | 145.67%72.32M | 103.15%25.24M | 184.62%18.57M | 169.92%14.43M | 173.79%14.07M | 102.39%29.44M | 172.04%12.43M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 92.30%35.72M | 119.29%31.64M | 94.71%27.4M | 145.67%72.32M | 103.15%25.24M | 184.62%18.57M | 169.92%14.43M | 173.79%14.07M | 102.39%29.44M | 172.04%12.43M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 77.21%0.0381 | 88.27%0.0337 | 79.55%0.0316 | 134.24%0.0862 | 90.97%0.0296 | 162.20%0.0215 | 167.16%0.0179 | 175.00%0.0176 | 102.20%0.0368 | 171.93%0.0155 |
| Diluted earnings per share | 84.08%0.037 | 97.01%0.0329 | 92.90%0.0299 | 108.33%0.07 | 90.67%0.0286 | 151.25%0.0201 | 153.03%0.0167 | 142.19%0.0155 | 87.71%0.0336 | 177.78%0.015 |
| Dividend per share | 60.00%0.012 | 0.0085 | 0 | 435.71%0.015 | 0.0075 | 167.86%0.0075 | 0 | 0 | 33.33%0.0028 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.